Mizuho raises target for Cardinal Health stock to USD 280.00

Published on 10/27/2026 at 16:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fiscal 2027 earnings guidance is USD 12.40-12.60. Cardinal Health stock costs EUR 223.30 on October 27, 2026 at 4:34 p.m. CEST.

Mizuho target and earnings outlook

Mizuho raised its Cardinal Health target from USD 250.00 to USD 280.00 on October 20, 2026.
Fiscal 2027 earnings guidance stands at USD 12.40-12.60 per share.
Cardinal Health stock traded at EUR 223.30 at Lang & Schwarz on October 27, 2026 at 4:34 p.m. CEST.
Cardinal Health plans to publish first-quarter fiscal 2027 results on November 5, 2026.

Cardinal Health, US14149Y1082, Illustration mit AI erstellt.

Cardinal Health (ISIN US14149Y1082) gained a higher valuation benchmark from Mizuho, which lifted its price target from USD 250.00 to USD 280.00 on October 20, 2026. The company also guides to fiscal 2027 adjusted earnings per share of USD 12.40-12.60, according to MarketBeat. Cardinal Health was trading at EUR 223.30 at Lang & Schwarz on October 27, 2026 at 4:34 p.m. CEST.

Target rises as guidance holds

Mizuho maintained an outperform rating while raising its target by USD 30.00. The new target is 12.00 percent above the former USD 250.00 level, a concrete change in the analyst view rather than a revision to company guidance.

Cardinal Health's latest reported quarter produced adjusted earnings per share of USD 2.91 against consensus of USD 2.42, while revenue increased 5.80 percent year over year to USD 63.67 billion. The figures and the fiscal 2027 guidance were reported by MarketBeat.

Revenue scale keeps margins in view

The fiscal 2026 report showed revenue of USD 254.25 billion and net income attributable to Cardinal Health of USD 1.71 billion. Revenue increased 14.23 percent from USD 222.58 billion in fiscal 2025, while net income rose 9.80 percent over the same comparison.

That combination leaves the operating picture highly dependent on volume and execution. The latest quarter's 5.80 percent revenue growth was paired with a guidance range that gives investors a specific earnings yardstick for fiscal 2027.

Next results arrive November 5

Cardinal Health plans to release first-quarter fiscal 2027 results on November 5, 2026, before trading begins on the New York Stock Exchange, according to Cardinal Health. The release will provide the next reported comparison for the USD 12.40-12.60 full-year earnings outlook.

Valuation and market position

Cardinal Health had a market capitalization of USD 58.62 billion and a price-to-earnings ratio of 35.02 in the market data cited by MarketBeat on October 20, 2026. The company is listed on the NYSE under ticker CAH and operates in pharmaceutical and medical distribution.

Stock stays tied to earnings delivery

Mizuho's USD 280.00 target, the USD 12.40-12.60 outlook and the November 5 reporting date form the next measurable checkpoints for Cardinal Health stock. The euro quotation stood at EUR 223.30 at Lang & Schwarz on October 27, 2026 at 4:34 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Cardinal Health stock.